ATBPF   $0.3819  -4.53% Market Closed

Antibe Therapeutics Inc
Total Cash 24.91M
totalCashPerShare 0.473
EBITDA
Total Debt 0.00
quickRatio 9.139
currentRatio 10.055
Total Revenue
debtToEquity
Revenue/Share
ROA -0.19128999
ROE -0.52725
grossProfits
freeCashflow -12.28M
operatingCashflow -18.25M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -8.15M
forwardPE -1.2865386
floatShares 49.24M
sharesOutstanding 52.67M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.08%
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.492
Price To Book help_outline 0.68
earningsQuarterlyGrowth
netIncomeToCommon -18.24M
trailingEps -0.25%
forwardEps -0.26%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.08 1Q 2024
institutionsCount 0
lastUpdated April 1, 2024, 2:56 p.m.